Pemetrexed (ALIMTA, MTA) is a novel thymidylate synthase (TS) inhibitor and has shown activity against colon cancer, mesothelioma and nonsmall-cell lung cancer. We induced resistance to Pemetrexed in the human colon cancer cell line WiDr by using a continuous exposure to stepwise increasing Pemetrexed concentrations (up to 20 microM) as well as a more clinically relevant schedule with intermittent exposure (up to 50 microM) for 4 hr every 7 days, resulting in WiDr variants WiDr-cPEM and WiDr-4PEM, respectively. However, using the same conditions, it was not possible to induce resistance in the WiDr/F cell line, a variant adapted to growth under low folate conditions. Mechanisms of resistance to Pemetrexed were determined at the level of TS,...
A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and...
Thymidylate synthase (TS) is an important target for chemotherapy and can be inhibited by 5-fluorour...
Colorectal cancer (CRC) resistance to fluoropyrimidines and other inhibitors of thymidylate synthase...
Pemetrexed (ALIMTA, MTA) is a novel thymidylate synthase (TS) inhibitor and has shown activity again...
Although treatment options for cancer patients are increasing every year, the drug resistance proble...
Although treatment options for cancer patients are increasing every year, the drug resistance proble...
Thymidylate synthase (TS), a critical enzyme in the de novo synthesis of thymidylate, is an importan...
The cytotoxicity and metabolic effects of two thymidylate synthase (TS) inhibitors, Tomudex (Raltitr...
Thymidylate synthase (TS) is a key enzyme in the de novo synthesis of 2'-deoxythymidine-5'-monophosp...
AbstractThymidylate synthase (TS) is a key enzyme in the de novo synthesis of 2′-deoxythymidine-5′-m...
AbstractZD9331 is an antifolate drug that potently and specifically inhibits thymidylate synthase (T...
We determined the mechanisms of resistance of human CCRF-CEM leukemia cells to methotrexate (MTX) vs...
Malignant pleural mesothelioma (MPM) is an invasive malignancy that develops in the pleural cavity, ...
AbstractDrug resistance is often a limiting factor in successful chemotherapy. Our laboratory has be...
ABSTRACT Tumor cell resistance to fluoropyrimidines and other inhibitors of thymidylate synthase (TS...
A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and...
Thymidylate synthase (TS) is an important target for chemotherapy and can be inhibited by 5-fluorour...
Colorectal cancer (CRC) resistance to fluoropyrimidines and other inhibitors of thymidylate synthase...
Pemetrexed (ALIMTA, MTA) is a novel thymidylate synthase (TS) inhibitor and has shown activity again...
Although treatment options for cancer patients are increasing every year, the drug resistance proble...
Although treatment options for cancer patients are increasing every year, the drug resistance proble...
Thymidylate synthase (TS), a critical enzyme in the de novo synthesis of thymidylate, is an importan...
The cytotoxicity and metabolic effects of two thymidylate synthase (TS) inhibitors, Tomudex (Raltitr...
Thymidylate synthase (TS) is a key enzyme in the de novo synthesis of 2'-deoxythymidine-5'-monophosp...
AbstractThymidylate synthase (TS) is a key enzyme in the de novo synthesis of 2′-deoxythymidine-5′-m...
AbstractZD9331 is an antifolate drug that potently and specifically inhibits thymidylate synthase (T...
We determined the mechanisms of resistance of human CCRF-CEM leukemia cells to methotrexate (MTX) vs...
Malignant pleural mesothelioma (MPM) is an invasive malignancy that develops in the pleural cavity, ...
AbstractDrug resistance is often a limiting factor in successful chemotherapy. Our laboratory has be...
ABSTRACT Tumor cell resistance to fluoropyrimidines and other inhibitors of thymidylate synthase (TS...
A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and...
Thymidylate synthase (TS) is an important target for chemotherapy and can be inhibited by 5-fluorour...
Colorectal cancer (CRC) resistance to fluoropyrimidines and other inhibitors of thymidylate synthase...